<DOC>
	<DOCNO>NCT00589862</DOCNO>
	<brief_summary>It recommend patient drug-eluting stent place coronary artery take aspirin Plavix ( Clopidogrel ) least year . Patients stop take antiplatelet drug resistance antiplatelet effect drug high risk clot occur inside stent may result heart attack . At present time , unknown increase dos antiplatelet agent effective overcome resistance . The purpose project identify patient antiplatelet drug resistance test whether increase Plavix ( Clopidogrel ) dose overcomes antiplatelet drug resistance .</brief_summary>
	<brief_title>Clinical Management Antiplatelet Drug Resistance Patients With Drug Eluting Coronary Stents</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Required Coronary Artery Angioplasty drugeluting stent deployment The last drugeluting stent place great 2 week prior Aspirin Plavix ( Clopidogrel ) allergy contraindication</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Drug Eluting Stents</keyword>
	<keyword>Clopidogrel Resistance</keyword>
	<keyword>Aspirin Resistance</keyword>
</DOC>